US Patent 8232372 Engineered anti-TSLP antibody
Patent 8232372 was granted and assigned to Schering on July, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+170 characters)
Article
Patent abstract
The invention relates to binding compounds that specifically bind to human TSLP, as well as uses thereof, e.g., in the treatment of inflammatory disorders.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Leonard G. Presta0
Rene de Waal Malefyt0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08232372 Engineered anti-TSLP antibody US Patent 8232372 Engineered anti-TSLP antibody
Infobox
Patent Number
082323720
Patent Number
82323720
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082323720
Date of Patent
July 31, 2012
0Patent Application Number
125159150
Date Filed
December 13, 2007
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08232372 Engineered anti-TSLP antibody
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08232372
Date of patent
July 31, 2012
Patent application number
12515915
Date Filed
December 13, 2007
Patent primary examiner
Find more entities like US Patent 8232372 Engineered anti-TSLP antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
